123 related articles for article (PubMed ID: 29408378)
1. FBW7 suppresses cell proliferation and G2/M cell cycle transition via promoting γ-catenin K63-linked ubiquitylation.
Li Y; Hu K; Xiao X; Wu W; Yan H; Chen H; Chen Z; Yin D
Biochem Biophys Res Commun; 2018 Mar; 497(2):473-479. PubMed ID: 29408378
[TBL] [Abstract][Full Text] [Related]
2. FBW7 targets KLF10 for ubiquitin-dependent degradation.
Yu S; Wang F; Tan X; Gao GL; Pan WJ; Luan Y; Ge X
Biochem Biophys Res Commun; 2018 Jan; 495(2):2092-2097. PubMed ID: 29198712
[TBL] [Abstract][Full Text] [Related]
3. Proteasomal degradation of the tumour suppressor FBW7 requires branched ubiquitylation by TRIP12.
Khan OM; Almagro J; Nelson JK; Horswell S; Encheva V; Keyan KS; Clurman BE; Snijders AP; Behrens A
Nat Commun; 2021 Apr; 12(1):2043. PubMed ID: 33824312
[TBL] [Abstract][Full Text] [Related]
4. FBW7 is associated with prognosis, inhibits malignancies and enhances temozolomide sensitivity in glioblastoma cells.
Lin J; Ji A; Qiu G; Feng H; Li J; Li S; Zou Y; Cui Y; Song C; He H; Lu Y
Cancer Sci; 2018 Apr; 109(4):1001-1011. PubMed ID: 29427543
[TBL] [Abstract][Full Text] [Related]
5. The F-box protein FBXL16 up-regulates the stability of C-MYC oncoprotein by antagonizing the activity of the F-box protein FBW7.
Morel M; Shah KN; Long W
J Biol Chem; 2020 Jun; 295(23):7970-7980. PubMed ID: 32345600
[TBL] [Abstract][Full Text] [Related]
6. FBW7 regulates DNA interstrand cross-link repair by modulating FAAP20 degradation.
Wang J; Jo U; Joo SY; Kim H
Oncotarget; 2016 Jun; 7(24):35724-35740. PubMed ID: 27232758
[TBL] [Abstract][Full Text] [Related]
7. The Fbw7/human CDC4 tumor suppressor targets proproliferative factor KLF5 for ubiquitination and degradation through multiple phosphodegron motifs.
Liu N; Li H; Li S; Shen M; Xiao N; Chen Y; Wang Y; Wang W; Wang R; Wang Q; Sun J; Wang P
J Biol Chem; 2010 Jun; 285(24):18858-67. PubMed ID: 20388706
[TBL] [Abstract][Full Text] [Related]
8. Fbw7 regulates apoptosis in activated B-cell like diffuse large B-cell lymphoma by targeting Stat3 for ubiquitylation and degradation.
Yao S; Xu F; Chen Y; Ge Y; Zhang F; Huang H; Li L; Lin D; Luo X; Xu J; Luo D; Zhu X; Liu Y
J Exp Clin Cancer Res; 2017 Jan; 36(1):10. PubMed ID: 28069035
[TBL] [Abstract][Full Text] [Related]
9. FBW7 suppresses ovarian cancer development by targeting the N
Xu F; Li J; Ni M; Cheng J; Zhao H; Wang S; Zhou X; Wu X
Mol Cancer; 2021 Mar; 20(1):45. PubMed ID: 33658012
[TBL] [Abstract][Full Text] [Related]
10. Ubiquitin Ligase, Fbw7, Targets CDX2 for Degradation via Two Phosphodegron Motifs in a GSK3β-Dependent Manner.
Kumar Y; Shukla N; Thacker G; Kapoor I; Lochab S; Bhatt ML; Chattopadhyay N; Sanyal S; Trivedi AK
Mol Cancer Res; 2016 Nov; 14(11):1097-1109. PubMed ID: 27470268
[TBL] [Abstract][Full Text] [Related]
11. Wingless and Archipelago, a fly E3 ubiquitin ligase and a homolog of human tumor suppressor FBW7, show an antagonistic relationship in wing development.
Nam S; Cho KO
BMC Dev Biol; 2020 Jun; 20(1):14. PubMed ID: 32594913
[TBL] [Abstract][Full Text] [Related]
12. E3 ubiquitin ligase Fbw7 negatively regulates granulocytic differentiation by targeting G-CSFR for degradation.
Lochab S; Pal P; Kapoor I; Kanaujiya JK; Sanyal S; Behre G; Trivedi AK
Biochim Biophys Acta; 2013 Dec; 1833(12):2639-2652. PubMed ID: 23820376
[TBL] [Abstract][Full Text] [Related]
13. The Fbw7 tumor suppressor targets KLF5 for ubiquitin-mediated degradation and suppresses breast cell proliferation.
Zhao D; Zheng HQ; Zhou Z; Chen C
Cancer Res; 2010 Jun; 70(11):4728-38. PubMed ID: 20484041
[TBL] [Abstract][Full Text] [Related]
14. Fbw7 promotes ubiquitin-dependent degradation of c-Myb: involvement of GSK3-mediated phosphorylation of Thr-572 in mouse c-Myb.
Kitagawa K; Hiramatsu Y; Uchida C; Isobe T; Hattori T; Oda T; Shibata K; Nakamura S; Kikuchi A; Kitagawa M
Oncogene; 2009 Jun; 28(25):2393-405. PubMed ID: 19421138
[TBL] [Abstract][Full Text] [Related]
15. Physiological functions of FBW7 in cancer and metabolism.
Shimizu K; Nihira NT; Inuzuka H; Wei W
Cell Signal; 2018 Jun; 46():15-22. PubMed ID: 29474981
[TBL] [Abstract][Full Text] [Related]
16. Pan-cancer transcriptional signatures predictive of oncogenic mutations reveal that Fbw7 regulates cancer cell oxidative metabolism.
Davis RJ; Gönen M; Margineantu DH; Handeli S; Swanger J; Hoellerbauer P; Paddison PJ; Gu H; Raftery D; Grim JE; Hockenbery DM; Margolin AA; Clurman BE
Proc Natl Acad Sci U S A; 2018 May; 115(21):5462-5467. PubMed ID: 29735700
[TBL] [Abstract][Full Text] [Related]
17. Dependence of Human Colorectal Cells Lacking the FBW7 Tumor Suppressor on the Spindle Assembly Checkpoint.
Bailey ML; Singh T; Mero P; Moffat J; Hieter P
Genetics; 2015 Nov; 201(3):885-95. PubMed ID: 26354767
[TBL] [Abstract][Full Text] [Related]
18. SCF
Huang LY; Zhao J; Chen H; Wan L; Inuzuka H; Guo J; Fu X; Zhai Y; Lu Z; Wang X; Han ZG; Sun Y; Wei W
Nat Commun; 2018 Sep; 9(1):3569. PubMed ID: 30177679
[TBL] [Abstract][Full Text] [Related]
19. PRMT5 enhances tumorigenicity and glycolysis in pancreatic cancer via the FBW7/cMyc axis.
Qin Y; Hu Q; Xu J; Ji S; Dai W; Liu W; Xu W; Sun Q; Zhang Z; Ni Q; Zhang B; Yu X; Xu X
Cell Commun Signal; 2019 Mar; 17(1):30. PubMed ID: 30922330
[TBL] [Abstract][Full Text] [Related]
20. Multivalent Interactions with Fbw7 and Pin1 Facilitate Recognition of c-Jun by the SCF
Csizmok V; Montecchio M; Lin H; Tyers M; Sunnerhagen M; Forman-Kay JD
Structure; 2018 Jan; 26(1):28-39.e2. PubMed ID: 29225075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]